of infants at risk for group B strep
The intensive and prolonged observation of infants at risk for group B streptococcus (GBS) may not benefit the infant and may heighten parental anxiety, researchers at the Yale School of Medicine report in a recent article in Obstetrics & Gynecology.
Current guidelines from the Centers for Disease Control and Prevention (CDC) recommend at least four hours of antibiotics to treat GBS in pregnant women in labor. About 50% of women with GBS are unable to receive the full four hours of treatment due to rapid labor and delivery. The CDC considers their newborns "at risk" for GBS and recommends blood tests and 48 hours of observation in the hospital.
Researchers from the Departments of Obstetrics, Gynecology & Reproductive Sciences (Ob/Gyn), and Epidemiology & Public Health (EPH) sought evidence to support the CDC guidelines. They conducted a systematic review of all published studies that included the duration of GBS antibiotic treatment of women in the delivery room and the numbers of infants who developed GBS. They calculated risk ratios for GBS colonization or sepsis based on duration of treatment.
"Neither the pharmacologic literature nor the clinical literature provide evidence to support the current CDC guidelines about duration of antibiotic prophylaxis during labor," says Dr. Jessica Illuzzi, assistant professor in Yale Ob/Gyn, who conducted the study with Michael Bracken, the Susan Dwight Bliss Professor of Epidemiology in EPH and professor of neurology and Ob/Gyn.
"The current protocol results in large numbers of low-risk newborns undergoing invasive, expensive neonatal testing and prolonged observation, despite the lack of evidence that this group of infants is at higher risk for GBS infection," Illuzzi adds.
She says the pharmacologic literature reveals that effective levels of antibiotics are detectable in the fetal bloodstream and amniotic fluid as early as five minutes after treatment begins. The risk of neonatal GBS infection is also significantly reduced after one to two hours of treatment.
"Ultimately, we hope the CDC guidelines will be re-evaluated and revised to reflect the evidence so that resources, invasive testing and prolonged observation are directed to infants truly at risk for GBS disease," says Illuzzi.
Future research by Illuzzi and Bracken will include a possible prospective study to measure the duration of treatment and the spread of GBS among newborns.
-- By Karen Peart
T H I S
W E E K ' SS T O R I E S
Revolutionary discoveries in nanoscience announced
Team's research brings quantum mechanics to a larger scale
Synthesis breakthrough allows nanowires to act as biodetectors
Levin calls for action on global warming
'Goals for Goals' is boosting awareness of maternal health issues
YaleGlobal Online crosses 100-million mark in number of 'hits'
Fleury named new director of YINQE
'Made for Love' explores ways affection was depicted in art
Divinity School hosting 'Voices and Votes' symposium
Yale Opera to stage a new production of Puccini's romantic tale . . .
Research shows mitochondrial protein maintains appetite during fasting
Molecule's role in congenital brain malformation is identified
Design innovations of Amsterdam-based UNStudio are the focus . . .
Study questions intensive monitoring of infants at risk for group B strep
Study: Better communication needed regarding mammogram results
Scientists learn how leading cause of food-borne illness . . .
Talk will examine ways to restore America's 'damaged foreign policy'
Implications of road development in the Amazon to be examined
Shot-putter breaks 57-year-old record
IN MEMORIAM
Bulletin Home|Visiting on Campus|Calendar of Events|In the News
Bulletin Board|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs|News Releases|
E-Mail Us|Yale Home